Pres. & Chief Med. & Dev. Off. · Senti Biosciences Holdings, Inc. · Common Stock
Side
F
Value
—
Shares
20.0K
Price
—
Executed
Oct 21, 2026
Disclosed
Oct 23, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 21 executedOct 23, 2026 disclosed
SNTI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 57.1% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Rajangam Kanya filed this Form 4 reporting a tax withholding of SNTI on Oct 21, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Pres. & Chief Med. & Dev. Off.
Rajangam Kanyacik:0001816676
Issuer
Senti Biosciences Holdings, Inc.cik:0001854270
Revision history · 0
No field has changed since this record was first ingested.
